Skip to main content
. Author manuscript; available in PMC: 2016 Aug 31.
Published in final edited form as: Clin Pharmacol Ther. 2007 Mar;81(3):328–345. doi: 10.1038/sj.clpt.6100087

Table 1.

Advantages of current asthma pharmacogenetic study design

Technique Advantage How implemented
Screening algorithm Helps address multiple comparisons issues Screen using non-informative families before performing FBAT analysis
Family-based association test Population stratification is not an issue FBAT testing methodology using probands and parents
Principal components analysis Increases statistical power Each longitudinal outcome measure contributes to the observations
Replication population testing Helps to assure generalizability and address false positives Two population-based replication studies for each gene identified via screening, before confirmation
Functional studies Extends association studies into the functional domain Use of gene expression, in vitro, and animal models to test specific candidate genes and variants